What does the Anupam Rasayan India Limited (ANURAS) stock page cover?

Anupam Rasayan India Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for ANURAS?

Anupam Rasayan India Limited is currently shown with a delayed price near ₹1,143.5, P/E 74.35.

Does the ANURAS page provide investment advice?

No. The ANURAS page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Stocks›Chemicals

Watch Alert

Anupam Rasayan India Limited

ANURAS · NSE · Chemicals · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹1,143.50

−₹38.50 (−3.26%)(1D)

₹1,053.6052 Week Range₹1,415.00

Anvest Score

49/100

Valuation

46/100

Quality

24/100

Growth

80/100

Health

64/100

Momentum

41/100

Valuation
46
Quality
24
Growth
80
Health
64
Momentum
41

Loading company profile…

More Page Context

Research at a glance

Anupam Rasayan India Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹1,143.5

Market cap

₹13,024 Cr

P/E ratio

74.35

P/B ratio

3.91

Dividend yield

Not available

ROE

Not available

RSI 14

47.46

1Y return

Not available

Anupam Rasayan India Limited FAQs

3 topics

Expand

Stocks›Chemicals

Watch Alert

Anupam Rasayan India Limited

ANURAS · NSE · Chemicals · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹1,143.50

−₹38.50 (−3.26%)(1D)

₹1,053.6052 Week Range₹1,415.00

Anvest Score

49/100

Valuation

46/100

Quality

24/100

Growth

80/100

Health

64/100

Momentum

41/100

Valuation
46
Quality
24
Growth
80
Health
64
Momentum
41

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Anupam Rasayan India Limited manufactures agrochemicals, personal care ingredients, pharmaceuticals, and performance materials. The company serves global clients, earning revenue primarily from its agrochemical segment.

Specialty ChemicalsGlobal FootprintFounded:1984CEO/MD:Anand S. DesaiHQ:Surat, Gujarat

Business profile as of 2026-08-25

Business at a Glance

These segments produce intermediates and active ingredients for crop protection, personal care, APIs, and other applications.

Revenue growth: +64.6%FY26 growth+13.9%3Y CAGR
EPS growth: +77.5%FY26 growth-10.2%3Y CAGR
CFO / PAT: 1.50×FY26

What Looks Strong

GrowthRevenue grew at +13.9% CAGR over three years.
Cash FlowOperating cash flow was 1.50× total net profit in FY26.
Balance SheetConservative capital structure with manageable leverage of 0.39× Debt/Equity.

What to Watch

EarningsEarnings contracted at -10.2% CAGR over the 3-year period. Watch whether cost rationalization and operational recovery arrest the decline.
MarginsOperating margin compressed from ~20.8% to ~16.3% in FY26 (consolidated). Watch input costs and pricing in the next two results.
ValuationThe shares trade at 74× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.
TrendPrice is 9% below its 200-day moving average, indicating a weak long-term price trend.

Reports a single operating segment in its results filings.
The company generates revenue by manufacturing and supplying advanced intermediates and specialty chemicals through custom synthesis and contract manufacturing.
They cater to diverse end-user industries, providing tailored chemical solutions that require complex chemistries and processes.

FY26 (consolidated): revenue ₹2,365 cr, up 65% from ₹1,437 cr in FY25; net profit ₹222 cr, up 39% from ₹160 cr in FY25.
FY26 (consolidated): operating cash flow ₹334 cr (1.5× net profit); debt/equity 0.39×.
Latest quarter to Jun 2026 (consolidated): revenue ₹655 cr (up 35% year on year); net profit ₹51.2 cr.

Loading company profile…

More Page Context

Research at a glance

Anupam Rasayan India Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹1,143.5

Market cap

₹13,024 Cr

P/E ratio

74.35

P/B ratio

3.91

Dividend yield

Not available

ROE

Not available

RSI 14

47.46

1Y return

Not available

Anupam Rasayan India Limited FAQs

3 topics

Expand

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Anupam Rasayan India Limited manufactures agrochemicals, personal care ingredients, pharmaceuticals, and performance materials. The company serves global clients, earning revenue primarily from its agrochemical segment.

Specialty ChemicalsGlobal FootprintFounded:1984CEO/MD:Anand S. DesaiHQ:Surat, Gujarat

Business profile as of 2026-08-25

Business at a Glance

These segments produce intermediates and active ingredients for crop protection, personal care, APIs, and other applications.

Revenue growth: +64.6%FY26 growth+13.9%3Y CAGR
EPS growth: +77.5%FY26 growth-10.2%3Y CAGR
CFO / PAT: 1.50×FY26

What Looks Strong

GrowthRevenue grew at +13.9% CAGR over three years.
Cash FlowOperating cash flow was 1.50× total net profit in FY26.
Balance SheetConservative capital structure with manageable leverage of 0.39× Debt/Equity.

What to Watch

EarningsEarnings contracted at -10.2% CAGR over the 3-year period. Watch whether cost rationalization and operational recovery arrest the decline.
MarginsOperating margin compressed from ~20.8% to ~16.3% in FY26 (consolidated). Watch input costs and pricing in the next two results.
ValuationThe shares trade at 74× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.
TrendPrice is 9% below its 200-day moving average, indicating a weak long-term price trend.

Reports a single operating segment in its results filings.
The company generates revenue by manufacturing and supplying advanced intermediates and specialty chemicals through custom synthesis and contract manufacturing.
They cater to diverse end-user industries, providing tailored chemical solutions that require complex chemistries and processes.

FY26 (consolidated): revenue ₹2,365 cr, up 65% from ₹1,437 cr in FY25; net profit ₹222 cr, up 39% from ₹160 cr in FY25.
FY26 (consolidated): operating cash flow ₹334 cr (1.5× net profit); debt/equity 0.39×.
Latest quarter to Jun 2026 (consolidated): revenue ₹655 cr (up 35% year on year); net profit ₹51.2 cr.

Anupam Rasayan India Limited

Research at a glance

Anupam Rasayan India Limited FAQs

Anupam Rasayan India Limited

Business at a Glance

What Looks Strong

What to Watch

Research at a glance

Anupam Rasayan India Limited FAQs

Related paths

Related insights

BASF

SPLPETRO

PRIVISCL

Eliminating Look-Ahead Bias in Indian Fundamental Backtests

Business at a Glance

What Looks Strong

What to Watch